ePharmaPedia http://www.epharmapedia.com ePharmapedia Thu, 23 Feb 2017 00:19:37 +0000 http://www.epharmapedia.com/images/logo.jpg ePharmaPedia.com http://www.epharmapedia.com 61 Children in Cambodia Dead Due to Unknown Disease http://www.epharmapedia.com/news/details/26/3054/61-Children-in-Cambodia-Dead-Due-to-Unknown-Disease.html?lang=en <table/> <tr> <td> – After an unknown disease killed 61 children during the last three months in the South-East Asian country of Cambodia, the World Health Organization is collaborating with Cambodia’s Health Ministry to investigate this incident. </td> </tr> </table> 2012-07-07 FDA approves Stendra for erectile dysfunction http://www.epharmapedia.com/news/details/26/2452/FDA-aproves-Stendra-for-erectile-dysfunction.html?lang=en <table/> <tr> <td> - The U.S. Food and Drug Administration today approved Stendra , a new drug to treat erectile dysfunction. </td> </tr> </table> 2012-04-28 Malaria: 60 times-rate increase due to lack of funding http://www.epharmapedia.com/news/details/26/2432/Malaria-60-times-rate-increase-due-to-lack-of-funding.html?lang=en <table/> <tr> <td> – The incidence rate of malaria has increased from 100 thousand per year to 6 million per year, says a new study. </td> </tr> </table> 2012-04-25 FDA Add New Side effect to Birth Control Pills Labels http://www.epharmapedia.com/news/details/26/2318/FDA-Ad-New-Side-efect-to-Birth-Control-Pils-Labels.html?lang=en <table/> <tr> <td> - The U.S. Food and Drug Administration has completed today its review of recent observational studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills. </td> </tr> </table> 2012-04-11 Cancer Medication without Active Ingredient http://www.epharmapedia.com/news/details/26/2267/Cancer-Medication-without-Active-Ingredient.html?lang=en <table/> <tr> <td> - FDA lab tests have confirmed that a counterfeit version of Roche’s Altuzan 400mg/16ml , an injectable cancer medication, found in the U.S. contains no active ingredient. </td> </tr> </table> 2012-04-05 Medical Team in Iraq Cut Out 16Kg Ovarian Tumor http://www.epharmapedia.com/news/details/26/2179/Medical-Team-in-Iraq-Cut-Out-16Kg-Ovarian-Tumor.html?lang=en <table/> <tr> <td> – A medical team at "Ba'quba's Hospital" excised a 16 Kg tumor from a patient's abdomen, the tumor was connected to the left ovary. The tumor was big enough to occupy all the abdomen space, which precluded its correct visualization using ultrasound prior to the operation. </td> </tr> </table> 2012-03-26 Mercury Poisoning Linked to Skin Products http://www.epharmapedia.com/news/details/26/2088/Mercury-Poisoning-Linked-to-Skin-Products.html?lang=en <table/> <tr> <td> – “If you have a product that matches these descriptions, stop using it immediately,” says Gary Coody, national health fraud coordinator in the Food and Drug Administration’s Office of Regulatory Affairs in a new warning. </td> </tr> </table> 2012-03-11 New Guidelines to Avoid Dangerous Infection in Hospitals: CDC Report http://www.epharmapedia.com/news/details/26/2075/New-Guidelines-to-Avoid-Dangerous-Infection-in-Hospitals-CDC-Report.html?lang=en <table/> <tr> <td> – Unlike the expected, hospital and healthcare facilities function as "transmitters" for many resistant diseases, and though most of them have declined significantly, the one caused by C.difficil has reached unprecedented levels of prevalence. CDC has issued new recommendations, which were published in Vital Sign, to control the upcoming hospital epidemic. </td> </tr> </table> 2012-03-10 American Physician Sentenced to Life Term for Pain Pill Prescriptions http://www.epharmapedia.com/news/details/26/2010/American-Physician-Sentenced-to-Life-Term-for-Pain-Pil-Prescriptions.html?lang=en <table/> <tr> <td> – A U.S physician, Paul Volkman was sentenced to four full terms in prison for prescribing pain pills outside the scope of necessary medical use, which resulted in four patients' death. </td> </tr> </table> 2012-03-01 "Statins": FDA Announces New Warnings to Be Added http://www.epharmapedia.com/news/details/26/2000/Statins-FDA-Anounces-New-Warnings-to-Be-Aded.html?lang=en <table/> <tr> <td> - Important safety changes to the labeling for some widely used cholesterol-lowering drugs known as statins are being announced today by the U.S. Food and Drug Administration. </td> </tr> </table> 2012-02-29 Quadruple limb transplant patient died on Monday http://www.epharmapedia.com/news/details/26/1998/Quadruple-limb-transplant-patient-died-on-Monday.html?lang=en <table/> <tr> <td> - Sevket Cavdar, the Turkish patient who had the first, four-limbs transplant in the world did not survive the complications and died on Monday, the hospital announced </td> </tr> </table> 2012-02-29 New Test To Detect H.Pylri Infection in Children http://www.epharmapedia.com/news/details/26/1985/New-Test-To-Detect-HPylri-Infection-in-Children.html?lang=en <table/> <tr> <td> – FDA approved the use of breath test in children to detect the bug that causes peptic ulcer disease.The test will be the first to be used in children aged between 13 and17, though it has been used since 1996 to detect the same germ, Helicobacter.pylori, in adults. </td> </tr> </table> 2012-02-28 Egyptian Health Ministry Denies Vaccinating Children in Their Homes http://www.epharmapedia.com/news/details/26/1984/Egyptian-Health-Ministry-Denies-Vacinating-Children-in-Their-Homes.html?lang=en <table/> <tr> <td> – The ministry of health in Egypt denied holding campaigns to vaccinate children inside their houses. The statement was released in face of rumors that said that "suspected" sources had been giving "harmful" vaccinations to children inside their houses claiming that they were a part of an official campaign launched by the health ministry. </td> </tr> </table> 2012-02-28 WHO Experts Suspend Publishing "Bird Flu" Researches: Fears of Bioterrorism http://www.epharmapedia.com/news/details/26/1962/WHO-Experts-Suspend-Publishing-Bird-Flu-Researches-Fears-of-Bioterorism.html?lang=en <table/> <tr> <td> A small group of global public health and influenza experts at a WHO meeting reached consensus on extending the temporary suspension of publishing researches related to the new laboratory-modified H5N1 viruses. </td> </tr> </table> 2012-02-25 FDA approves Korlym for patients with endogenous Cushing’s syndrome http://www.epharmapedia.com/news/details/26/1911/FDA-aproves-Korlym-for-patients-with-endogenous-Cushing’s-syndrome.html?lang=en <table/> <tr> <td> Today, Korlym was approved by the U.S. Food and Drug Administration to control high blood sugar levels in adults with endogenous Cushing’s syndrome. </td> </tr> </table> 2012-02-18 FDA approves Zioptan to treat elevated eye pressure http://www.epharmapedia.com/news/details/26/1891/FDA-aproves-Zioptan-to-treat-elevated-eye-presure.html?lang=en <table/> <tr> <td> Drug provides potentially sight-saving treatment for those with glaucoma </td> </tr> </table> 2012-02-15 FDA approves Gleevec for expanded use in patients with rare gastrointestinal cancer http://www.epharmapedia.com/news/details/26/1834/FDA-aproves-Glevec-for-expanded-use-in-patients-with-rare-gastrointestinal-cancer.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration today granted Gleevec regular approval for use in adult patients following surgical removal of CD117-positive gastrointestinal stromal tumors . </td> </tr> </table> 2012-02-05 FDA approves Kalydeco to treat rare form of cystic fibrosis http://www.epharmapedia.com/news/details/26/1825/FDA-aproves-Kalydeco-to-treat-rare-form-of-cystic-fibrosis.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration today approved Kalydeco for the treatment of a rare form of cystic fibrosis in patients ages 6 years and older who have the specific G551D mutation in the Cystic Fibrosis Transmembrane Regulator gene. </td> </tr> </table> 2012-02-02 FDA approves Inlyta to treat patients with a type of advanced kidney cancer http://www.epharmapedia.com/news/details/26/1824/FDA-aproves-Inlyta-to-treat-patients-with-a-type-of-advanced-kidney-cancer.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration today approved Inlyta to treat patients with advanced kidney cancer who have not responded to another drug for this type of cancer. </td> </tr> </table> 2012-02-01 FDA approves new treatment for most common type of skin cancer http://www.epharmapedia.com/news/details/26/1809/FDA-aproves-new-treatment-for-most-comon-type-of-skin-cancer.html?lang=en <table/> <tr> <td> Erivedge was approved by the U.S. Food and Drug Administration to treat adult patients with basal cell carcinoma, the most common type of skin cancer. </td> </tr> </table> 2012-01-31 Rasitrio Approved to Treat Essential Hypertension http://www.epharmapedia.com/news/details/26/1802/Rasitrio-Aproved-to-Treat-Esential-Hypertension.html?lang=en <table/> <tr> <td> Rasitrio is a medicine that contains the active substances aliskiren, amlodipine and hydrochlorothiazide. It is available as tablets in the following strengths: 150 /5/12.5 mg; 300/5/12.5 mg; 300/5/25 mg; 300/10/12.5 mg; and 300/10/25 mg. </td> </tr> </table> 2012-01-30 Obama Sets Date for Finding Alzheimer's Treatment http://www.epharmapedia.com/news/details/26/1795/Obama-Sets-Date-for-Finding-Alzheimers-Treatment.html?lang=en <table/> <tr> <td> The Obama administration has set a date for finding an effective treatment for Alzheimer’s disease. It is 2025—just 13 years away—not a prolonged period when it comes to solving a medical mystery that affects millions. </td> </tr> </table> 2012-01-29 Komboglyze Approved to Treat Diabetes Mellitus, Type 2 http://www.epharmapedia.com/news/details/26/1767/Komboglyze-Aproved-to-Treat-Diabetes-Melitus-Type-2.html?lang=en <table/> <tr> <td> Komboglyze is a medicine that contains the active substances saxagliptin and metformin. It is available as tablets . </td> </tr> </table> 2012-01-23 FDA approves to treat patients with toxic methotrexate levels http://www.epharmapedia.com/news/details/26/1763/FDA-aproves-to-treat-patients-with-toxic-methotrexate-levels.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration today approved Voraxaze to treat patients with toxic levels of methotrexate in their blood due to kidney failure. </td> </tr> </table> 2012-01-21 FDA approves first generic version of cholesterol-lowering drug Lipitor http://www.epharmapedia.com/news/details/26/1632/FDA-aproves-first-generic-version-of-cholesterol-lowering-drug-Lipitor.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration approved the first generic version of the cholesterol-lowering drug Lipitor . </td> </tr> </table> 2011-12-13 FDA Commissioner Removes Breast Cancer Indication from Avastin Label http://www.epharmapedia.com/news/details/26/1622/FDA-Comisioner-Removes-Breast-Cancer-Indication-from-Avastin-Label.html?lang=en <table/> <tr> <td> FDA Commissioner Margaret Hamburg is revoking the agency’s accelerated approval of the breast cancer indication for Avastin , manufactured by Genentech. </td> </tr> </table> 2011-12-11 FDA approves Eylea for eye disorder in older people Maintains clearness of vision in those with wet age-related macular degeneration http://www.epharmapedia.com/news/details/26/1620/FDA-aproves-Eylea-for-eye-disorder-in-older-people-Maintains-clearnes-of-vision-in-those-with-wet-age-related-macular-degeneration.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration approved Eylea to treat patients with wet age-related macular degeneration , a leading cause of vision loss and blindness in Americans ages 60 and older. </td> </tr> </table> 2011-12-11 FDA approves first drug to treat a rare bone marrow disease (myelofibrosis) http://www.epharmapedia.com/news/details/26/1614/FDA-aproves-first-drug-to-treat-a-rare-bone-marow-disease-myelofibrosis.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration approved Jakafi , the first drug approved to specifically treat patients with the bone marrow disease myelofibrosis. </td> </tr> </table> 2011-12-10 FDA approves Erbitux to treat late-stage head and neck cancer http://www.epharmapedia.com/news/details/26/1609/FDA-aproves-Erbitux-to-treat-late-stage-head-and-neck-cancer.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration approved Erbitux for use with chemotherapy to treat patients with late-stage head and neck cancer. </td> </tr> </table> 2011-12-06 FDA approves Xarelto to prevent stroke in people with common type of abnormal heart rhythm http://www.epharmapedia.com/news/details/26/1596/FDA-aproves-Xarelto-to-prevent-stroke-in-people-with-comon-type-of-abnormal-heart-rhythm.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration approved the anti-clotting drug Xarelto to reduce the risk of stroke in people who have abnormal heart rhythm . </td> </tr> </table> 2011-12-04 FDA approves first insomnia drug for middle-of-the-night waking followed by difficulty returning to sleep http://www.epharmapedia.com/news/details/26/1586/FDA-aproves-first-insomnia-drug-for-midle-of-the-night-waking-folowed-by-dificulty-returning-to-slep.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration approved Intermezzo for use as needed to treat insomnia characterized by middle-of-the-night waking followed by difficulty returning to sleep. </td> </tr> </table> 2011-12-03 Vyndaqel Approved to Delay Nerve Damage Caused by Transthyretin Amyloidosis http://www.epharmapedia.com/news/details/26/1582/Vyndaqel-Aproved-to-Delay-Nerve-Damage-Caused-by-Transthyretin-Amyloidosis.html?lang=en <table/> <tr> <td> Vyndaqel is used to delay nerve damage caused by transthyretin amyloidosis, a hereditary disease in which fibres called amyloid build up in tissues around the body including around the nerves. Vyndaqel is used in adult patients with the early stage of nerve disease . </td> </tr> </table> 2011-12-01 Keppra Approved to Treat Seizures http://www.epharmapedia.com/news/details/26/1579/Kepra-Aproved-to-Treat-Seizures.html?lang=en <table/> <tr> <td> Keppra is a medicine that contains the active substance levetiracetam. It is available as tablets , as an oral solution , and as a concentrate that is made up into a solution for infusion . </td> </tr> </table> 2011-12-01 FDA Drug Safety Podcast for Healthcare Professionals: UPDATE on Tumor Necrosis Factor (TNF) blockers and risk for pediatric malignancy http://www.epharmapedia.com/news/details/26/1563/FDA-Drug-Safety-Podcast-for-Healthcare-Profesionals-UPDATE-on-Tumor-Necrosis-Factor-TNF-blockers-and-risk-for-pediatric-malignancy.html?lang=en <table/> <tr> <td> On November 3, 2011, the Food and Drug Administration issued a Drug Safety Communication updating the public about its ongoing safety review of Tumor Necrosis Factor, or TNF, blockers and malignancy in children, adolescents, and young adults . </td> </tr> </table> 2011-11-28 FDA Drug Safety Podcast for Healthcare Professionals: Safety review update of Chantix (varenicline) and risk of neuropsychiatric adverse events http://www.epharmapedia.com/news/details/26/1558/FDA-Drug-Safety-Podcast-for-Healthcare-Profesionals-Safety-review-update-of-Chantix-varenicline-and-risk-of-neuropsychiatric-adverse-events.html?lang=en <table/> <tr> <td> On October 24, 2011, the Food and Drug Administration issued a Drug Safety Communication alerting the public that FDA has reviewed the results from two FDA-sponsored epidemiological studies that evaluated the risk of neuropsychiatric adverse events associated with the smoking cessation drug Chantix. </td> </tr> </table> 2011-11-27 Zoely Approved for contraception http://www.epharmapedia.com/news/details/26/1556/Zoely-Aproved-for-contraception.html?lang=en <table/> <tr> <td> Zoely is a medicine available as 24 white ‘active’ tablets that contain the active substances nomegestrol acetate and estradiol , and four yellow ‘inactive’ tablets that do not contain any active substance. </td> </tr> </table> 2011-11-27 Trajenta Approved for Treating Type II Diabetes http://www.epharmapedia.com/news/details/26/1555/Trajenta-Aproved-for-Treating-Type-I-Diabetes.html?lang=en <table/> <tr> <td> Trajenta is a medicine that contains the active substance linagliptin. It is available as tablets .Trajenta is used to treat type 2 diabetes mellitus. It is used together with metformin, or together with metformin and a sulphonylurea, when blood sugar is not already adequately controlled by diet, exercise and these antidiabetes medicines. </td> </tr> </table> 2011-11-26 FDA Approves Onfi to Treat Severe Type of Seizures http://www.epharmapedia.com/news/details/26/1552/FDA-Aproves-Onfi-to-Treat-Severe-Type-of-Seizures.html?lang=en <table/> <tr> <td> On Oct. 21, the U.S. Food and Drug Administration approved Onfi tablets for use as an adjunctive treatment for seizures associated with Lennox-Gastaut syndrome in adults and children 2 years of age and older. As Onfi is intended to treat a disease or condition that affects fewer than 200,000 people in the United States, it was granted orphan drug designation by the FDA. </td> </tr> </table> 2011-11-26 Fampyra approved to improve walking ability in MS patients http://www.epharmapedia.com/news/details/26/1473/Fampyra-aproved-to-improve-walking-ability-in-MS-patients.html?lang=en <table/> <tr> <td> Fampyra is a medicine that contains the active substance fampridine. It is available as prolonged-release tablets . </td> </tr> </table> 2011-11-01 Vibativ approved to treat nosocomial pneumonia http://www.epharmapedia.com/news/details/26/1467/Vibativ-aproved-to-treat-nosocomial-pneumonia.html?lang=en <table/> <tr> <td> Vibativ is a medicine that contains the active substance telavancin. It is available as a powder to be made up into a solution for infusion . </td> </tr> </table> 2011-10-31 Zytiga approved to treat prostate cancer http://www.epharmapedia.com/news/details/26/1463/Zytiga-aproved-to-treat-prostate-cancer.html?lang=en <table/> <tr> <td> Zytiga is a medicine that contains the active substance abiraterone acetate. It is available as tablets . </td> </tr> </table> 2011-10-30 Incivo approved to treat chronic hepatitis C http://www.epharmapedia.com/news/details/26/1457/Incivo-aproved-to-treat-chronic-hepatitis-C.html?lang=en <table/> <tr> <td> Incivo is a medicine that contains the active substance telaprevir. It is available as tablets . </td> </tr> </table> 2011-10-29 Buccolam (midazolam) approved to stop acute convulsive seizures in children http://www.epharmapedia.com/news/details/26/1455/Bucolam-midazolam-aproved-to-stop-acute-convulsive-seizures-in-children.html?lang=en <table/> <tr> <td> Buccolam is a medicine that contains the active substance midazolam. It is available as ‘oromucosal solution’ in prefilled syringes. Each syringe contains 2.5 mg, 5 mg, 7.5 mg or 10 mg of midazolam. </td> </tr> </table> 2011-10-29 FDA proposes lower risk classification, special controls for external pacemakers http://www.epharmapedia.com/news/details/26/1423/FDA-proposes-lower-risk-clasification-special-controls-for-external-pacemakers.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration has issued a proposed rule and draft special controls guidance lowering the risk classification for external pacemaker pulse generators from Class III to Class II . </td> </tr> </table> 2011-10-19 Dexdor to sedate adult patients in the ICUs dexmedetomidine http://www.epharmapedia.com/news/details/26/1417/Dexdor-to-sedate-adult-patients-in-the-ICUs-dexmedetomidine.html?lang=en <table/> <tr> <td> Dexdor is a medicine that contains the active substance dexmedetomidine. It is available as a concentrate to be made up into a solution for infusion . </td> </tr> </table> 2011-10-18 FDA approves Ferriprox to treat patients with excess iron in the body http://www.epharmapedia.com/news/details/26/1402/FDA-aproves-Feriprox-to-treat-patients-with-exces-iron-in-the-body.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration approved Ferriprox to treat patients with iron overload due to blood transfusions in patients with thalassemia, a genetic blood disorder that causes anemia, who had an inadequate response to prior chelation therapy. </td> </tr> </table> 2011-10-15 FDA approves Botox for loss of bladder control Regulatory http://www.epharmapedia.com/news/details/26/1396/FDA-aproves-Botox-for-los-of-blader-control-Regulatory.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration approved Allergan’s Botox for treating detrusor overactivity associated with a neurologic condition such as multiple sclerosis or spinal cord injury. </td> </tr> </table> 2011-10-13 FDA approves Cialis to treat benign prostatic hyperplasia http://www.epharmapedia.com/news/details/26/1375/FDA-aproves-Cialis-to-treat-benign-prostatic-hyperplasia.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration approved Cialis to treat the signs and symptoms of benign prostatic hyperplasia and for the treatment of BPH and erectile dysfunction , when the conditions occur simultaneously. </td> </tr> </table> 2011-10-10 FDA approves combination therapy Juvisync http://www.epharmapedia.com/news/details/26/1361/FDA-aproves-combination-therapy-Juvisync.html?lang=en <table/> <tr> <td> The U.S. Food and Drug Administration approved Juvisync , a fixed-dose combination prescription medication that contains two previously approved medicines in one tablet for use in adults who need both sitagliptin and simvastatin. </td> </tr> </table> 2011-10-08 Data on Astra's Crestor drug vs. Lipitor seen soon http://www.epharmapedia.com/news/details/26/1353/Data-on-Astras-Crestor-drug-vs-Lipitor-sen-son.html?lang=en <table/> <tr> <td> Headline results from an important clinical trial comparing AstraZeneca's cholesterol fighter Crestor to Pfizer's Lipitor could be released imminently, according to an analyst note. </td> </tr> </table> 2011-10-06